Daniel F. Hayes, MD, professor at the University of Michigan Comprehensive Cancer Center, discusses the future of biomarkers for patients with breast cancer.
Daniel F. Hayes, MD
Advertisement
Articles by Daniel F. Hayes, MD
Daniel F. Hayes, MD, professor of University of Michigan Comprehensive Cancer Center, discusses anti-estrogen therapy beyond 5 years in breast cancer.
Daniel F. Hayes, MD, professor University of Michigan Comprehensive Cancer Center, discusses the use of tumor biomarker tests in breast cancer.
Advertisement
Latest Updated Articles
Dr. Hayes Discusses Anti-Estrogen Therapy Beyond 5 Years in Breast CancerPublished: May 31st 2017 | Updated:
Dr. Hayes on the Future of Biomarkers for Breast CancerPublished: June 6th 2017 | Updated:
Dr. Hayes Discusses Tumor Biomarker Tests in Breast CancerPublished: March 17th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
The OncFive: Top Oncology Articles for the Week of 1/25
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5